High Humoral Response after Anti-Sars-Cov-2 mRNA-Based Vaccines in Patients with Active Multiple Myeloma (MM) and Relationship with Disease Status/Line of Therapy

mRNA vaccines BNT162b2 and mRNA1273 are highly effective in preventing SARS-CoV-2 infection and mortality in healthy adults. However, their immunogenicity in immunocompromised Multiple Myeloma (MM) patients is less clear. We performed an observational prospective study of 96 MM patients (pts) treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Katia, Zamagni, Elena, Solli, Vincenza, Gabrielli, Liliana, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Tacchetti, Paola, Fusco, Alessio, De Cicco, Gabriella, Ursi, Margherita, Talarico, Marco, Favero, Emanuele, Nepoti, Giuliana, Ruffini, Barbara, Terragna, Carolina, Lazzarotto, Tiziana, Zinzani, Pier Luigi, Cavo, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701594/
http://dx.doi.org/10.1182/blood-2021-150266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701594/
http://dx.doi.org/10.1182/blood-2021-150266

Ejemplares similares